Patient assistance

Free help paying for cancer medications.

mendmeds tracks 11 cancer medications, with 22 active assistance programs, each linked to its official source with the date we checked it.

Browse

Every cancer medication we cover

Calquence (acalabrutinib)Medicare options
2 active programs
Typically around $15,500 per month without assistance
Ibrance (palbociclib)Medicare options
2 active programs
Typically around $15,000 per month without assistance
Imbruvica (ibrutinib)Medicare options
2 active programs
Typically around $17,000 per month without assistance
Jakafi (ruxolitinib)
2 active programs
Typically around $16,000 per month without assistance
Keytruda (pembrolizumab)
2 active programs
Lynparza (olaparib)Medicare options
2 active programs
Typically around $17,000 per month without assistance
Pomalyst (pomalidomide)Medicare options
2 active programs
Typically around $24,000 per month without assistance
Revlimid (lenalidomide)Medicare options
2 active programs
Typically around $22,000 per month without assistance
Tagrisso (osimertinib)Medicare options
2 active programs
Typically around $19,000 per month without assistance
Verzenio (abemaciclib)Medicare options
2 active programs
Typically around $15,500 per month without assistance
Xtandi (enzalutamide)
2 active programs
Typically around $14,500 per month without assistance

Other conditions